title: A study to evaluate the effect of celecoxib as add-on to olanzapine therapy in schizophrenia.
authors.affiliation: Department of Pharmacology & Therapeutics, CSMMU, UP, Lucknow, India. Electronic address: tusharkgmu@yahoo.com.
authors.forename: Tushar
authors.initials: T
authors.lastname: Baheti
authors.affiliation: Department of Pharmacology & Therapeutics, CSMMU, UP, Lucknow, India. Electronic address: nischal.anuradha@gmail.com.
authors.forename: Anuradha
authors.initials: A
authors.lastname: Nischal
authors.affiliation: Department of Psychiatry, CSMMU, UP, Lucknow, India. Electronic address: an.kgmu@gmail.com.
authors.forename: Anil
authors.initials: A
authors.lastname: Nischal
authors.affiliation: Department of Pharmacology & Therapeutics, CSMMU, UP, Lucknow, India. Electronic address: drskhattri@gmail.com.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Khattri
authors.affiliation: Department of Psychiatry, CSMMU, UP, Lucknow, India. Electronic address: amitarya.11kgmu@gmail.com.
authors.forename: Amit
authors.initials: A
authors.lastname: Arya
authors.affiliation: Department of Psychiatry, CSMMU, UP, Lucknow, India. Electronic address: dradarshtripathi@gmail.com.
authors.forename: Adarsh
authors.initials: A
authors.lastname: Tripathi
authors.affiliation: Department of Pharmacology & Therapeutics, CSMMU, UP, Lucknow, India. Electronic address: pant.kamlesh@gmail.com.
authors.forename: K K
authors.initials: KK
authors.lastname: Pant
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use*; D000068579:Celecoxib; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D000077152:Olanzapine; D011569:Psychiatric Status Rating Scales; D011720:Pyrazoles / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D013449:Sulfonamides / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D052246:Cyclooxygenase 2 Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D001569:Benzodiazepines; D000068579:Celecoxib; D000077152:Olanzapine